A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
Open accessPublished version of a preprint
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Nissle 1917 is sold as a probiotic and considered safe even though it has been known since 2006 that it harbors the genes for colibactin synthesis. Colibactin is a potent genotoxin that is now linked to causative mutations found in human colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nissle 1917 contains the pks gene cluster that encodes a series of enzymes that produce a DNA alkylating and double-strand break-inducing genotoxin known as colibactin [23].”
From Selection, Comparative Genomics, and Potential Probiotic Features of Escherichia coli 5C, a pks-Negative Strain Isolated from Healthy Infant Donor Feces (2026) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the E. coli strain Nissle 1917, commonly used as a probiotic, also produces colibactin102”
From Human disease models in drug development (2023) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263 · cited 4×
“coli promote colorectal cancer in mouse models (16, 17), and the DNA mutational signature of colibactin has been found in cohorts of patients with colorectal cancer, including in the APC cancer driver gene (9, 11, 18).”
BackgroundInfluentialMechanisms of DNA damage, repair, and mutagenesis
Chatterjee, N., & Walker, G. C. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22087 · Cited by 2,039 · cited 1×
“Mitotic errors can lead to an accumulation of DNA damage, which in turn favors gene mutations (Chatterjee and Walker, 2017; Levine and Holland, 2018).”
BackgroundKruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 1×
“The use of Nissle 1917 is recommended for maintaining remission in ulcerative colitis (2, 3).”
BackgroundMutational signature in colorectal cancer caused by genotoxic pks+ E. coli
Pleguezuelos-Manzano, C., Puschhof, J., Rosendahl Huber, A., van Hoeck, A., Wood, H. M., Nomburg, J., Gurjao, C., Manders, F., Dalmasso, G., Stege, P. B., et al. (2020) · Nature · doi:10.1038/s41586-020-2080-8 · Cited by 1,208 · cited 7×
“coli promote colorectal cancer in mouse models (16, 17), and the DNA mutational signature of colibactin has been found in cohorts of patients with colorectal cancer, including in the APC cancer driver gene (9, 11, 18).”
BackgroundInfluentialDNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189 · cited 1×
“plex interplay between DNA repair, cell death, and survival (33).”
BackgroundEscherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006) · Science · doi:10.1126/science.1127059 · Cited by 1,188 · cited 1×
“recent biomedical literature, it was shown in 2006 that Nissle 1917 hosts a 54-kb pks island coding for nonribosomal and polyketide synthases (NRPS and PKS, respectively) allowing synthesis of a hybrid peptide-polyketide metabolite called colibactin (5, 6).”
BackgroundSelf-citationPatients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., et al. (2018) · Science · doi:10.1126/science.aah3648 · Cited by 1,105 · cited 1×
“Inflammation and dysbiosis are also known to allow the expansion of the E. coli population, including that of Nissle 1917, alongside the epithelium (Cevallos et al., 2019; Dejea et al., 2018; Zhu et al., 2019).”
BackgroundEscherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells
Cuevas-Ramos, G., Petit, C. R., Marcq, I., Boury, M., Oswald, E., & Nougayrède, J.-P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001261107 · Cited by 855 · cited 17×
“Infection with a MOI of 20 Nissle 1917 resulted in a significant increase of hprt mutation frequency.”
BackgroundResultSelf-citationThe landscape of somatic mutation in normal colorectal epithelial cells
Lee-Six, H., Olafsson, S., Ellis, P., Osborne, R. J., Sanders, M. A., Moore, L., Georgakopoulos, N., Torrente, F., Noorani, A., Goddard, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1672-7 · Cited by 747 · cited 2×
“…et al., 2020; Pleguezuelos-Manzano et al., 2020; Terlouw et al., 2020) and also in colonic crypts from healthy individuals under the age of ten (Lee-Six et al., 2019) proves that colibactin is expressed within the human gut (including in child), and links colibactin exposure to colorectal…”
BackgroundThe Human Gut Bacterial Genotoxin Colibactin Alkylates DNA
Wilson, M. R., Jiang, Y., Villalta, P. W., Stornetta, A., Boudreau, P. D., Carrá, A., Brennan, C. A., Chun, E., Ngo, L., Samson, L. D., et al. (2019) · Science · doi:10.1126/science.aar7785 · Cited by 635 · cited 5×
“(19) were inappropriate, in contrast to the assays used in the present and other works (12, 32), to highlight the DNA-damaging activity and genotoxicity of”
BackgroundMethodResultInfluentialIsabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4222 · Cited by 605 · cited 1×
“Engineered strains of Nissle 1917 have also been constructed to treat obesity through production of N- acylphosphatidylethanolamine (Chen et al., 2014) or to express a phenylalanine-metabolizing enzyme in response to the anoxic conditions in the gut, to treat phenylketonuria (Isabella et al., 2018).”
BackgroundMicrocins mediate competition among Enterobacteriaceae in the inflamed gut
Sassone-Corsi, M., Nuccio, S.-P., Liu, H., Hernandez, D., Vu, C. T., Takahashi, A. A., Edwards, R. A., & Raffatellu, M. (2016) · Nature · doi:10.1038/nature20557 · Cited by 549 · cited 4×
“…in vivo tests” (Dubbert et al., 2020) but the authors used assays that are suboptimal to demonstrate production and mutagenicity of colibactin, such as the use of Salmonella reporter bacteria that are killed by the microcins produced by Nissle 1917 (Massip et al., 2020; Sassone-Corsi et al., 2016).”
BackgroundInfluentialDeveloping a new class of engineered live bacterial therapeutics to treat human diseases
Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications · doi:10.1038/s41467-020-15508-1 · Cited by 523 · cited 2×
“, bacteria genetically designed to treat or prevent a disease) (42).”
BackgroundCougnoux, A., Dalmasso, G., Martinez, R., Buc, E., Delmas, J., Gibold, L., Sauvanet, P., Darcha, C., Déchelotte, P., Bonnet, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305257 · Cited by 486 · cited 2×
“coli promote colorectal cancer in mouse models (16, 17), and the DNA mutational signature of colibactin has been found in cohorts of patients with colorectal cancer, including in the APC cancer driver gene (9, 11, 18).”
BackgroundHwang, I. Y., Koh, E., Wong, A., March, J. C., Bentley, W. E., Lee, Y. S., & Chang, M. W. (2017) · Nature Communications · doi:10.1038/ncomms15028 · Cited by 472 · cited 2×
“enzyme against Pseudomonas aeruginosa (43) or a microcin induced upon sensing of Salmonella infection (44).”
BackgroundMethodMaréchal, A., & Zou, L. (2015) · Cell Research · doi:10.1038/cr.2014.147 · Cited by 465 · cited 1×
“that in turn phosphorylates RPA and histone variant H2AX (7, 29, 30).”
BackgroundArthur, J. C., Gharaibeh, R. Z., Mühlbauer, M., Perez-Chanona, E., Uronis, J. M., McCafferty, J., Fodor, A. A., & Jobin, C. (2014) · Nature Communications · doi:10.1038/ncomms5724 · Cited by 392 · cited 1×
“Importantly, intestinal inflammation was shown to upregulate pks genes (Arthur et al., 2014; Dubinsky et al., 2020; Yang et al., 2020).”
BackgroundColibactin DNA-damage signature indicates mutational impact in colorectal cancer
Dziubańska-Kusibab, P. J., Berger, H., Battistini, F., Bouwman, B. A. M., Iftekhar, A., Katainen, R., Cajuso, T., Crosetto, N., Orozco, M., Aaltonen, L. A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0908-2 · Cited by 319 · cited 2×
“coli promote colorectal cancer in mouse models (16, 17), and the DNA mutational signature of colibactin has been found in cohorts of patients with colorectal cancer, including in the APC cancer driver gene (9, 11, 18).”
BackgroundIncorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
Chen, Z., Guo, L., Zhang, Y., L. Walzem, R., Pendergast, J. S., Printz, R. L., Morris, L. C., Matafonova, E., Stien, X., Kang, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72517 · Cited by 277 · cited 2×
“Engineered strains of Nissle 1917 have also been constructed to treat obesity through production of N- acylphosphatidylethanolamine (Chen et al., 2014) or to express a phenylalanine-metabolizing enzyme in response to the anoxic conditions in the gut, to treat phenylketonuria (Isabella et al., 2018).”
BackgroundThe impact of mitotic errors on cell proliferation and tumorigenesis
Levine, M. S., & Holland, A. J. (2018) · Genes & Development · doi:10.1101/gad.314351.118 · Cited by 274 · cited 1×
“Mitotic errors can lead to an accumulation of DNA damage, which in turn favors gene mutations (Chatterjee and Walker, 2017; Levine and Holland, 2018).”
BackgroundThe Colibactin Genotoxin Generates DNA Interstrand Cross-Links in Infected Cells
Bossuet-Greif, N., Vignard, J., Taieb, F., Mirey, G., Dubois, D., Petit, C., Oswald, E., & Nougayrède, J.-P. (2018) · mBio · doi:10.1128/mbio.02393-17 · Cited by 260 · cited 9×
“Nissle 1917 produces colibactin and induces DNA crosslinks in infected epithelial cells DNA interstrand crosslinks generated by colibactin impair the denaturation of DNA and thus inhibits its electrophoretic mobility in denaturing conditions (Bossuet-Greif et al., 2018).”
BackgroundMethodSelf-citationThe colibactin warhead crosslinks DNA
Vizcaino, M. I., & Crawford, J. M. (2015) · Nature Chemistry · doi:10.1038/nchem.2221 · Cited by 247 · cited 2×
“(19) were inappropriate, in contrast to the assays used in the present and other works (12, 32), to highlight the DNA-damaging activity and genotoxicity of”
ResultDetection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity
Merk, O., & Speit, G. (1999) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1999)33:2<167::aid-em9>3.0.co;2-d · Cited by 231 · cited 2×
“cross-links that inhibit DNA electrophoretic mobility (7, 12, 31).”
BackgroundMethodRecommendations for Probiotic Use—2011 Update
Floch, M. H., Walker, W. A., Madsen, K., Sanders, M. E., Macfarlane, G. T., Flint, H. J., Dieleman, L. A., Ringel, Y., Guandalini, S., Kelly, C. P., et al. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318230928b · Cited by 206 · cited 2×
“The use of Nissle 1917 is recommended for maintaining remission in ulcerative colitis (Floch et al., 2011; Kruis et al., 2004).”
BackgroundMethodMode of action-based risk assessment of genotoxic carcinogens
Hartwig, A., Arand, M., Epe, B., Guth, S., Jahnke, G., Lampen, A., Martus, H.-J., Monien, B., Rietjens, I. M. C. M., Schmitz-Spanke, S., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02733-2 · Cited by 199 · cited 2×
“Genotoxic carcinogens are classically conceived to represent a risk factor with no threshold dose, because little numbers or even one DNA lesion may result in mutation and increased tumor risk (Hartwig et al., 2020).”
BackgroundScaldaferri, F., Gerardi, V., Mangiola, F., Lopetuso, L. R., Pizzoferrato, M., Petito, V., Papa, A., Stojanovic, J., Poscia, A., Cammarota, G., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i24.5505 · Cited by 194
Vassin, V. M., Anantha, R. W., Sokolova, E., Kanner, S., & Borowiec, J. A. (2009) · Journal of Cell Science · doi:10.1242/jcs.053702 · Cited by 187 · cited 2×
“that in turn phosphorylates RPA and histone variant H2AX (7, 29, 30).”
BackgroundA Prodrug Resistance Mechanism Is Involved in Colibactin Biosynthesis and Cytotoxicity
Brotherton, C. A., & Balskus, E. P. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312154m · Cited by 186 · cited 2×
“Similarly, no cross-linking activity was detected with the Nissle 1917 strain mutated for the peptidase ClbP that cleaves the inactive precolibactin to release the cleavage product C14-Asn and generate the mature active colibactin (23) (Fig.”
BackgroundIftekhar, A., Berger, H., Bouznad, N., Heuberger, J., Boccellato, F., Dobrindt, U., Hermeking, H., Sigal, M., & Meyer, T. F. (2021) · Nature Communications · doi:10.1038/s41467-021-21162-y · Cited by 174 · cited 2×
“…crosslinks the opposite strands of DNA, resulting in DNA damages and gene mutagenesis in eukaryotic cells (Bossuet-Greif et al., 2018; Cuevas-Ramos et al., 2010; Dziubańska-Kusibab et al., 2020; Iftekhar et al., 2021; Nougayrède et al., 2006; Pleguezuelos-Manzano et al., 2020; Wilson et al., 2019).”
BackgroundResultOlier, M., Marcq, I., Salvador-Cartier, C., Secher, T., Dobrindt, U., Boury, M., Bacquié, V., Penary, M., Gaultier, E., Nougayrède, J.-P., et al. (2012) · Gut Microbes · doi:10.4161/gmic.21737 · Cited by 159 · cited 1×
“The clbA and clbP isogenic mutants were described previously (48, 49).”
MethodSelf-citationInterplay between Siderophores and Colibactin Genotoxin Biosynthetic Pathways in Escherichia coli
Martin, P., Marcq, I., Magistro, G., Penary, M., Garcie, C., Payros, D., Boury, M., Olier, M., Nougayrède, J.-P., Audebert, M., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003437 · Cited by 138 · cited 3×
“Colibactin is a virulence factor during systemic infection (Marcq et al., 2014; Martin et al., 2013; McCarthy et al., 2015), and plays a substantial role in colorectal cancer.”
BackgroundSelf-citationPalmer, J. D., Piattelli, E., McCormick, B. A., Silby, M. W., Brigham, C. J., & Bucci, V. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00114 · Cited by 133 · cited 2×
“enzyme against Pseudomonas aeruginosa (43) or a microcin induced upon sensing of Salmonella infection (44).”
BackgroundMethodPérez-Berezo, T., Pujo, J., Martin, P., Le Faouder, P., Galano, J.-M., Guy, A., Knauf, C., Tabet, J. C., Tronnet, S., Barreau, F., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01403-9 · Cited by 125
Zhu, W., Miyata, N., Winter, M. G., Arenales, A., Hughes, E. R., Spiga, L., Kim, J., Sifuentes-Dominguez, L., Starokadomskyy, P., Gopal, P., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181939 · Cited by 124 · cited 1×
“Inflammation and dysbiosis are also known to allow the expansion of the E. coli population, including that of Nissle 1917, alongside the epithelium (Cevallos et al., 2019; Dejea et al., 2018; Zhu et al., 2019).”
BackgroundLodinová-Žádniková, R., & Sonnenborn, U. (1997) · Neonatology · doi:10.1159/000244421 · Cited by 118 · cited 2×
“to persist in the human gut for months after inoculation (39).”
BackgroundGenetic engineering of probiotic Escherichia coli Nissle 1917 for clinical application
Ou, B., Yang, Y., Tham, W. L., Chen, L., Guo, J., & Zhu, G. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7829-5 · Cited by 111 · cited 2×
“Nissle 1917 is also a popular chassis to engineer therapeutic bacteria for vaccine, diagnostics, biosensors and drug development (Ou et al., 2016).”
BackgroundMassip, C., Branchu, P., Bossuet-Greif, N., Chagneau, C. V., Gaillard, D., Martin, P., Boury, M., Sécher, T., Dubois, D., Nougayrède, J.-P., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1008029 · Cited by 107
Self-citationExpression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli
Homburg, S., Oswald, E., Hacker, J., & Dobrindt, U. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00889.x · Cited by 103 · cited 2×
“recent biomedical literature, it was shown in 2006 that Nissle 1917 hosts a 54-kb pks island coding for nonribosomal and polyketide synthases (NRPS and PKS, respectively) allowing synthesis of a hybrid peptide-polyketide metabolite called colibactin (5, 6).”
BackgroundHenker, J., Laass, M. W., Blokhin, B. M., Maydannik, V. G., Bolbot, Y. K., Elze, M., Wolff, C., Schreiner, A., & Schulze, J. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318169034c · Cited by 100 · cited 1×
“has been shown in infants and toddlers with diarrhea (40).”
BackgroundYang, Y., Gharaibeh, R. Z., Newsome, R. C., & Jobin, C. (2020) · Nature Cancer · doi:10.1038/s43018-020-0078-7 · Cited by 98 · cited 1×
“Importantly, intestinal inflammation was shown to upregulate pks genes (Arthur et al., 2014; Dubinsky et al., 2020; Yang et al., 2020).”
BackgroundIncreased Epithelial Oxygenation Links Colitis to an Expansion of Tumorigenic Bacteria
Cevallos, S. A., Lee, J., Tiffany, C. R., Byndloss, A. J., Johnston, L., Byndloss, M. X., & Bäumler, A. J. (2019) · mBio · doi:10.1128/mbio.02244-19 · Cited by 93 · cited 1×
“Inflammation and dysbiosis are also known to allow the expansion of the E. coli population, including that of Nissle 1917, alongside the epithelium (Cevallos et al., 2019; Dejea et al., 2018; Zhu et al., 2019).”
BackgroundCigarette smoke induces anaphase bridges and genomic imbalances in normal cells
Luo, L., Werner, K. M., Gollin, S. M., & Saunders, W. S. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.031 · Cited by 88 · cited 2×
“Abnormal anaphase quantification was performed as described previously (51).”
MethodMcCarthy, A. J., Martin, P., Cloup, E., Stabler, R. A., Oswald, E., & Taylor, P. W. (2015) · Infection and Immunity · doi:10.1128/iai.00716-15 · Cited by 87 · cited 1×
“Colibactin is a virulence factor during systemic infection (Marcq et al., 2014; Martin et al., 2013; McCarthy et al., 2015), and plays a substantial role in colorectal cancer.”
BackgroundMarcq, I., Martin, P., Payros, D., Cuevas-Ramos, G., Boury, M., Watrin, C., Nougayrede, J.-P., Olier, M., & Oswald, E. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu071 · Cited by 80 · cited 1×
“Colibactin is a virulence factor during systemic infection (Marcq et al., 2014; Martin et al., 2013; McCarthy et al., 2015), and plays a substantial role in colorectal cancer.”
BackgroundSelf-citationProbiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids
Pradhan, S., & Weiss, A. A. (2020) · mBio · doi:10.1128/mbio.01470-20 · Cited by 80
Carriage of Colibactin-producing Bacteria and Colorectal Cancer Risk
Dubinsky, V., Dotan, I., & Gophna, U. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.05.015 · Cited by 76 · cited 3×
“Colibactin is now a suspected prooncogenic driver especially in IBD patients (Dubinsky et al., 2020).”
BackgroundSilva, M. J., Costa, P., Dias, A., Valente, M., Louro, H., & Boavida, M. G. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20138 · Cited by 57 · cited 2×
“Analysis of mutant frequencies was performed using a two-tailed t test on the log-transformed data to ensure data normality and to correct variance heterogeneity (26).”
MethodResultTang-Fichaux, M., Chagneau, C. V., Bossuet‐Greif, N., Nougayrède, J., Oswald, É., & Branchu, P. (2020) · mSphere · doi:10.1128/msphere.01195-20 · Cited by 48 · cited 1×
“After HeLa cell infection in 6-wells plates, 1ml of the cell supernatant containing the bacteria was collected, the samples were lysed by bead beating, the lipids were separated by solid-phase extraction, and C14-Asn was quantified by high-performance liquid chromatography coupled to mass spectrometry at the MetaToul…”
MethodSelf-citationTerlouw, D., Suerink, M., Boot, A., van Wezel, T., Nielsen, M., & Morreau, H. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.055 · Cited by 35 · cited 4×
“coli promote colorectal cancer in mouse models (16, 17), and the DNA mutational signature of colibactin has been found in cohorts of patients with colorectal cancer, including in the APC cancer driver gene (9, 11, 18).”
BackgroundInfluentialLeiomyoma of the Female Urethra
Deka, P. M., & Rajeev, T. P. (2003) · Urologia Internationalis · doi:10.1159/000071854 · Cited by 33
Dubbert, S., Klinkert, B., Schimiczek, M., Wassenaar, T. M., & Bünau, R. V. (2020) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2019.00025 · Cited by 24 · cited 6×
“(19) were inappropriate, in contrast to the assays used in the present and other works (12, 32), to highlight the DNA-damaging activity and genotoxicity of”
BackgroundMethodResultInfluentialMassip, C., Chagneau, C. V., Boury, M., & Oswald, É. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.01.001 · Cited by 19
Self-citationColibactin DNA damage signature indicates causative role in colorectal cancerPreprint
Dziubańska-Kusibab, P. J., Berger, H., Battistini, F., Bouwman, B. A. M., Iftekhar, A., Katainen, R., Crosetto, N., Orozco, M., Aaltonen, L. A., & Meyer, T. F. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/819854 · Cited by 12
[On coli antagonism, dysbacteria and coli therapy].
Nissle, A. (1959) · PubMed · Cited by 4
Cited by
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Bell, H. N., Rebernick, R. J., Goyert, J., Singhal, R., Kuljanin, M., Kerk, S. A., Huang, W., Das, N. K., Andren, A., Solanki, S., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.001 · Cited by 296
“Recent studies have advanced insights into the mechanisms by which pathogenic bacteria promote tumor growth and survival, such as by inducing inflammation, generating biofilms, and secreting genotoxins (Dejea et al., 2018, Pleguezuelos-Manzano et al., 2020; Tomkovich et al., 2019; Nougayrede et al., 2021).”
BackgroundEmerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch, J. P., Goers, L., & Lesser, C. F. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.002 · Cited by 230
Clean-label alternatives for food preservation: An emerging trend
Chauhan, K., & Rao, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35815 · Cited by 177
Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut
Lynch, J. P., González-Prieto, C., Reeves, A. Z., Bae, S., Powale, U., Godbole, N. P., Tremblay, J. M., Schmidt, F. I., Ploegh, H. L., Kansra, V. V., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.007 · Cited by 139
Metadata
- Authors
- Nougayrède, J.-P., Chagneau, C. V., Motta, J.-P., Bossuet-Greif, N., Belloy, M., Taieb, F., Gratadoux, J.-J., Thomas, M., Langella, P., & Oswald, E.
- Affiliations
- Inserm (FR)
- IRSD, INSERM, INRAE, Université de Toulouse, ENVT, Toulouse, France
- Microbiologie de l’alimentation au service de la santé (FR)
- Corresponding author
- Nougayrède, Jean-Philippe
- ORCID
- Venue
- mSphere
- Publisher
- American Society for Microbiology
- Published
- 2021-08-25
- Volume
- 6
- Issue
- 4
- Pages
- e0062421-e0062421
- ISSN
- 2379-5042 (ISSN-L)
- PMC
- PMC8386472
- OpenAlex
- W3190012438
- Cited by
- 82
- References
- 54
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 21 · 2023: 15 · 2022: 15 · 2021: 4
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- mSphere (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Institut National Du Cancer (PLBIO13-123)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- Escherichia coli Nissle 1917, probiotics, colibactin, genotoxicity, mutagenicity, colorectal cancer, bacterial genotoxins, probiotic safety
- MeSH terms
- Animals, Cricetulus, DNA Damage, Epithelial Cells, Escherichia coli, Escherichia coli Infections, Female, HeLa Cells, Humans, Mutation, Mutagenesis, CHO Cells, Genome, Bacterial, Probiotics, Escherichia coli Proteins, Genomic Islands, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.